Inhibition of microRNA-19b promotes ovarian granulosa cell proliferation by targeting IGF-1 in polycystic ovary syndrome Retraction in /10.3892/mmr.2023.13057

Zhong,Zhuohui; Li,Fang; Li,Yingying; Qin,Shuang; Wen,Canliang; Fu,Yiyuan; Xiao,Qing

doi:10.3892/mmr.2018.8463

Inhibition of microRNA-19b promotes ovarian granulosa cell proliferation by targeting IGF-1 in polycystic ovary syndrome

Retraction in: /10.3892/mmr.2023.13057

Authors:
- Zhuohui Zhong
- Fang Li
- Yingying Li
- Shuang Qin
- Canliang Wen
- Yiyuan Fu
- Qing Xiao
View Affiliations

Affiliations: Department of General Gynaecology, Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong 510623, P.R. China, Department of Obstetrics and Gynecology, Eighth People's Hospital of Guangzhou, Guangzhou, Guangdong 510060, P.R. China
Published online on: January 22, 2018 https://doi.org/10.3892/mmr.2018.8463
Pages: 4889-4898
Copyright: © Zhong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The purpose of the present study was to investigate the functional role of microRNA (miR)-19b in polycystic ovary syndrome (PCOS) and try to elucidate its underlying mechanisms. Expression of miR‑19b and insulin‑like growth factor 1 (IGF-1) was examined in ovarian cortexes [(from 18 women with PCOS and 10 who did not have PCOS (non‑PCOS)] and KGN cells. Cell proliferation assays (cell viability and colony formation assay) were performed following overexpression or inhibition of miR‑19b and IGF‑1 or following insulin treatment in KGN cells. Expression levels of the cell cycle-associated protein cyclin D1 and cyclin‑dependent kinase (CDK) 1 were analyzed following overexpression or inhibition of miR-19b and IGF-1. Potential miR‑19b targets were identified by bioinformatics. Luciferase assay, reverse transcription‑quantitative polymerase chain reaction and western blotting were performed to determine whether IGF‑1 was a target of miR‑19b. miR‑19b expression was significantly decreased in the PCOS ovarian cortex and KGN cells and its identified target, IGF‑1, was upregulated. miR‑19b overexpression inhibited cell proliferation at G2/M phrase. Overexpression of IGF‑1 promoted cell viability and colony formation ability in KGN cells. The expression of cyclin D1 and CDK1 was statistically increased by inhibition of miR‑19b and overexpression of IGF‑1. High concentrations of insulin decreased levels of miR‑19b, stimulated KGN cell proliferation, and elevated IGF‑1 levels. Inhibition of miR‑19b promoted ovarian granulosa cell proliferation by targeting IGF‑1 in PCOS. Insulin decreased the expression levels of miR‑19b and stimulated cell proliferation. The present study suggested that overexpression of miR‑19b may be a potential therapeutic approach for PCOS.

View Figures

View References

1	Madnani N, Khan K, Chauhan P and Parmar G: Polycystic ovarian syndrome. Indian J Dermatol Venereol Leprol. 79:310–321. 2013. View Article : Google Scholar : PubMed/NCBI
2	Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE and Witchel SF: Positions statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline. J Clin Endocrinol Metab. 91:4237–4245. 2006. View Article : Google Scholar : PubMed/NCBI
3	Trikudanathan S: Polycystic ovarian syndrome. Med Clin North Am. 99:221–235. 2015. View Article : Google Scholar : PubMed/NCBI
4	Legro RS, Kunselman AR, Dodson WC and Dunaif A: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 84:165–169. 1999. View Article : Google Scholar : PubMed/NCBI
5	Lindholm A, Andersson L, Eliasson M, Bixo M and Sundstrom-Poromaa I: Prevalence of symptoms associated with polycystic ovary syndrome. Int J Gynaecol Obstet. 102:39–43. 2008. View Article : Google Scholar : PubMed/NCBI
6	Fearnley EJ, Marquart L, Spurdle AB, Weinstein P and Webb PM; Australian Ovarian Cancer Study Group and Australian National Endometrial Cancer Study Group, : Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: An Australian case-control study. Cancer Causes Control. 21:2303–2308. 2010. View Article : Google Scholar : PubMed/NCBI
7	Das M, Djahanbakhch O, Hacihanefioglu B, Saridogan E, Ikram M, Ghali L, Raveendran M and Storey A: Granulosa cell survival and proliferation are altered in polycystic ovary syndrome. J Clin Endocrinol Metab. 93:881–887. 2008. View Article : Google Scholar : PubMed/NCBI
8	Erickson GF, Magoffin DA, Garzo VG, Cheung AP and Chang RJ: Granulosa cells of polycystic ovaries: Are they normal or abnormal? Hum Reprod. 7:293–299. 1992. View Article : Google Scholar : PubMed/NCBI
9	Ying SY, Chang DC, Miller JD and Lin SL: The microRNA: Overview of the RNA gene that modulates gene functions. Methods Mol Biol. 342:1–18. 2006.PubMed/NCBI
10	Dehwah MA, Xu A and Huang Q: MicroRNAs and type 2 diabetes/obesity. J Genet Genomics. 39:11–18. 2012. View Article : Google Scholar : PubMed/NCBI
11	Sang Q, Yao Z, Wang H, Feng R, Wang H, Zhao X, Xing Q, Jin L, He L, Wu L and Wang L: Identification of microRNAs in human follicular fluid: Characterization of microRNAs that govern steroidogenesis in vitro and are associated with polycystic ovary syndrome in vivo. J Clin Endocrinol Metab. 98:3068–3079. 2013. View Article : Google Scholar : PubMed/NCBI
12	Sørensen AE, Wissing ML, Salö S, Englund AL and Dalgaard LT: MicroRNAs related to polycystic ovary syndrome (PCOS). Genes (Basel). 5:684–708. 2014. View Article : Google Scholar : PubMed/NCBI
13	Jiang L, Huang J, Li L, Chen Y, Chen X, Zhao X and Yang D: MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome. J Clin Endocrinol Metab. 100:E729–E738. 2015. View Article : Google Scholar : PubMed/NCBI
14	Jiang L, Huang J, Chen Y, Yang Y, Li R, Li Y, Chen X and Yang D: Identification of several circulating microRNAs from a genome-wide circulating microRNA expression profile as potential biomarkers for impaired glucose metabolism in polycystic ovarian syndrome. Endocrine. 53:280–290. 2016. View Article : Google Scholar : PubMed/NCBI
15	Sirotkin AV, Lauková M, Ovcharenko D, Brenaut P and Mlyncek M: Identification of microRNAs controlling human ovarian cell proliferation and apoptosis. J Cell Physiol. 223:49–56. 2010.PubMed/NCBI
16	McCallie B, Schoolcraft WB and Katz-Jaffe MG: Aberration of blastocyst microRNA expression is associated with human infertility. Fertil Steril. 93:2374–2382. 2010. View Article : Google Scholar : PubMed/NCBI
17	Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 81:19–25. 2004. View Article : Google Scholar
18	Yoshiji H, Kuriyama S, Yoshii J, Yamazaki M, Kikukawa M, Tsujinoue H, Nakatani T and Fukui H: Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells. Hepatology. 28:1489–1496. 1998. View Article : Google Scholar : PubMed/NCBI
19	Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, Gao B, Schuster K, Shao C, Larsen JE, Sullivan LA, et al: Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res. 70:9937–9948. 2010. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) methods. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Lv D, Ding S, Chen P, Bei Y, Zhong C and Xiao J: Abstract 221: miR-19b protects myocardial ischemia reperfusion injury. Cir Res. 117:A2212015.
22	Baldin V, Lukas J, Marcote MJ, Pagano M and Draetta G: Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812–821. 1993. View Article : Google Scholar : PubMed/NCBI
23	Hu X and Moscinski LC: Cdc2: A monopotent or pluripotent CDK? Cell Prolif. 44:205–211. 2011. View Article : Google Scholar : PubMed/NCBI
24	Huat TJ, Khan AA, Pati S, Mustafa Z, Abdullah JM and Jaafar H: IGF-1 enhances cell proliferation and survival during early differentiation of mesenchymal stem cells to neural progenitor-like cells. BMC Neurosci. 15:912014. View Article : Google Scholar : PubMed/NCBI
25	Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR and LeRoith D: Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest. 110:771–781. 2002. View Article : Google Scholar : PubMed/NCBI
26	Thierry van Dessel HJ, Lee PD, Faessen G, Fauser BC and Giudice LC: Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome. J Clin Endocrinol Metab. 84:3030–3035. 1999. View Article : Google Scholar : PubMed/NCBI
27	Amin AF, Abd el-Aal DE, Darwish AM and Meki AR: Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor and insulin-like growth factor-1 in women with polycystic ovary syndrome. Fertil Steril. 79:938–941. 2003. View Article : Google Scholar : PubMed/NCBI
28	Abd El Aal DE, Mohamed SA, Amine AF and Meki AR: Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow. Eur J Obstet Gynecol Reprod Biol. 118:219–224. 2005. View Article : Google Scholar : PubMed/NCBI
29	Bergh C, Carlsson B, Olsson JH, Selleskog U and Hillensjö T: Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil Steril. 59:323–331. 1993. View Article : Google Scholar : PubMed/NCBI
30	Cara JF and Rosenfield RL: Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology. 123:733–739. 1988. View Article : Google Scholar : PubMed/NCBI
31	Cara JF: Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production. Horm Res. 42:49–54. 1994. View Article : Google Scholar : PubMed/NCBI
32	Franks S: Polycystic ovary syndrome. N Engl J Med. 333:853–861. 1995. View Article : Google Scholar : PubMed/NCBI
33	Utiger RD: Insulin and the polycystic ovary syndrome. N Engl J Med. 335:657–658. 1996. View Article : Google Scholar : PubMed/NCBI
34	Dunaif A: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 18:774–800. 1997. View Article : Google Scholar : PubMed/NCBI
35	Willis D, Mason H, Gilling-Smith C and Franks S: Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab. 81:302–309. 1996. View Article : Google Scholar : PubMed/NCBI